Ignite Creation Date:
2024-05-05 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00480246
Status:
COMPLETED
Last Update Posted:
2009-07-21
First Post:
2007-05-28
Brief Title:
A Positron Emission Tomography PET Study to Assess the Degree of Dopamine-2 D2 Receptor Occupancy in the Human Brain After Single Doses of BL-1020 or Perphenazine in Healthy Male Subjects Using 11CRaclopride as PET Tracer
Sponsor:
BioLineRx Ltd
Organization:
BioLineRx Ltd
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2007-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a single dose open-label 2-panel Parts A and B PET study investigating the degree of occupancy of dopamine 2 receptors D2_RO in the human brain after single oral doses of BL-1020 or Perphenazine Trilafon hereafter called Perphenazine in healthy male subjects In Part A the D2_RO is investigated for the study compound BL-1020 and in Part B the D2_RO of BL-1020 is compared to the D2_RO of Perphenazine a reference compound
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None